Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Neslihan Sinim Kahraman"'
Autor:
Ayşe Öner, Neslihan Sinim Kahraman, Mehmet Orkun Sevik, Kübra Kelek Tülü, Özlem Şahin, Saliha Özsoy
Publikováno v:
Türk Oftalmoloji Dergisi, Vol 54, Iss 4, Pp 205-211 (2024)
Objectives: To evaluate the incidence and severity of depression in patients with retinitis pigmentosa (RP). Materials and Methods: The Beck Depression Inventory (BDI) was administered to 74 patients with RP and 60 healthy controls. Biomicroscopic a
Externí odkaz:
https://doaj.org/article/34aab9c64a644d45b2537579beb2f835
Autor:
Ayşe Öner, Neslihan Sinim Kahraman
Publikováno v:
Türk Oftalmoloji Dergisi, Vol 54, Iss 1, Pp 23-31 (2024)
Objectives:The full-field stimulus threshold (FST) test was developed to evaluate the efficacy and safety of treatments of hereditary retinal diseases. In this study we performed the FST test in patients with retinitis pigmentosa (RP) and compared th
Externí odkaz:
https://doaj.org/article/e9b760cd766a4320904da4e88838dd2d
Publikováno v:
Türk Oftalmoloji Dergisi, Vol 52, Iss 4, Pp 270-275 (2022)
Objectives:Hereditary retinal dystrophies are a rare group of diseases which are heterogeneous in genotype and phenotype and result in total blindness. One of the genetic defects that cause hereditary retinal dystrophy is mutation of the RPE65 gene.
Externí odkaz:
https://doaj.org/article/dad5e2e310ab48c2846b2c62327a7717
Autor:
Neslihan Sinim Kahraman, Ayse Oner
Publikováno v:
International Journal of Ophthalmology, Vol 13, Iss 9, Pp 1423-1429 (2020)
AIM: To investigate the efficacy and the safety of umbilical cord derived mesenchymal stem cell (UC-MSC) implantation in patients with retinitis pigmentosa (RP). METHODS: This prospective, single-center, phase 3 clinical study enrolled 124 eyes of 8
Externí odkaz:
https://doaj.org/article/50b906c4e6234c0998f6c13d00893a26
Autor:
Ayşe Öner, Neslihan Sinim Kahraman
Publikováno v:
Trakya University Journal of Natural Sciences, Vol 20, Pp 11-16 (2019)
Use of stem cells in the treatment of retinal diseases is a new and popular topic in ophthalmology. Embryonic and bone marrow derived stem cells can be used for treatment. Age-related macular degeneration, Stargardt’s macular dystrophy and retiniti
Externí odkaz:
https://doaj.org/article/e897878ebfd941cf95c29773d06937c9
Autor:
Ayse Oner, Neslihan Sinim Kahraman
Publikováno v:
Open Journal of Ophthalmology. 13:37-47
Publikováno v:
Turkish journal of ophthalmology. 52(4)
Hereditary retinal dystrophies are a rare group of diseases which are heterogeneous in genotype and phenotype and result in total blindness. One of the genetic defects that cause hereditary retinal dystrophy is mutation of theThe data of patients dia
Autor:
Neslihan Sinim Kahraman, Ayse Oner
Publikováno v:
Open Journal of Ophthalmology. 11:36-48
Background: Cell replacement therapies have been evaluated in recent years as an alternative for various retinal pathologies to evaluate the therapeutic efficacy of cell therapy, it is important to measure the severity of the disease. The aim of this
Autor:
Ayse Oner, Neslihan Sinim Kahraman
Publikováno v:
Open Journal of Ophthalmology. 11:203-213
Background: The aim of this study was to evaluate vision related quality of life (VRQoL) in patients with retinitis pigmentosa (RP) after suprachoroidal umbilical cord derived mesenchymal stem cell (UC-MSC) treatment. Methods: The patients were evalu
Autor:
Ayse Oner, Neslihan Sinim Kahraman
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 36:609-617
Purpose: In this study, the aim was to evaluate the safety of transcorneal electrical stimulation (TES) treatment in retinitis pigmentosa (RP) patients and to investigate the effect of TES to the v...